Download
s12890-020-1108-z (2).pdf 1,56MB
WeightNameValue
1000 Titel
  • Diagnostic procedure for idiopathic eosinophilic pleural effusion: a single-center experience
1000 Autor/in
  1. Luo, Weizhan |
  2. Zeng, Yunxiang |
  3. Shen, Panxiao |
  4. He, Jianxing |
  5. Wang, Jinlin |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-03
1000 Erschienen in
1000 Quellenangabe
  • 20:82
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12890-020-1108-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126480/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Eosinophilic pleural effusion (EPE) is attributed to several well-recognised causes. However, some patients remain idiopathic, even after thorough clinical work-up. The present study aimed to better characterize idiopathic EPE (IEPE) and to outline the diagnostic procedure for this disease. METHODS: Complete clinical data of 11 consecutive patients with IEPE were prospectively collected and analysed. Preliminary diagnostic procedure of IEPE in our hospital was performed. RESULTS: All the 11 patients had respiratory symptoms and unilateral pleural effusion (PE) occurred in 4 patients. The mean percentage of eosinophils in PE was 22.4% (range, 12.4–50.5%). Lactate dehydrogenase, adenosine deaminase, proteins and carcinoembryonic antigen in PE were 246.0 U/L (range, 89.8–421.9 U/L), 13.8 U/L (range, 1.8–24.0 U/L), 42.6 g/dl (range, 32.8–52.6 g/dl) and 2.17 mg/mL (range, 0.46–4.31 mg/mL), respectively. Parasite-specific IgG antibody in blood and parasite eggs in stool were both negative. No evidence of tuberculosis or malignancy was observed in pleural biopsy. Symptoms and abnormal pulmonary imaging were eliminated after glucocorticoid use. CONCLUSIONS: IEPE is a diagnosis of exclusion. Patients with EPE without a clear cause should be asked to provided complete medical, surgical and drug-related histories. A thorough work-up is essential. Moreover, we recommend follow-up after the use of glucocorticoid until effusion resolves. TRIAL REGISTRATION: GYFYY. Registration No: GYFYY20150901221. Registered time: 1 September 2015. Date of enrolment of the first participant to the trial: 22 January 2016.
1000 Sacherschließung
lokal Glucocorticoid
lokal Eosinophilic pleural effusion
lokal Diagnosis
lokal Idiopathic
lokal Diagnostic procedure
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/THVvLCBXZWl6aGFu|https://frl.publisso.de/adhoc/uri/WmVuZywgWXVueGlhbmc=|https://frl.publisso.de/adhoc/uri/U2hlbiwgUGFueGlhbw==|https://frl.publisso.de/adhoc/uri/SGUsIEppYW54aW5n|https://frl.publisso.de/adhoc/uri/V2FuZywgSmlubGlu
1000 Label
1000 Förderer
  1. Guangzhou Institute of Respiratory Health |
1000 Fördernummer
  1. GIRH201503
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Guangzhou Institute of Respiratory Health |
    1000 Förderprogramm -
    1000 Fördernummer GIRH201503
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6423794.rdf
1000 Erstellt am 2020-10-29T10:41:46.461+0100
1000 Erstellt von 5
1000 beschreibt frl:6423794
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Wed Nov 04 07:39:15 CET 2020
1000 Objekt bearb. Fri Oct 30 09:13:58 CET 2020
1000 Vgl. frl:6423794
1000 Oai Id
  1. oai:frl.publisso.de:frl:6423794 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source